Kuros Biosciences AG
SIX:KURN

Watchlist Manager
Kuros Biosciences AG Logo
Kuros Biosciences AG
SIX:KURN
Watchlist
Price: 29.2 CHF 3.36% Market Closed
Market Cap: 1.1B CHF
Have any thoughts about
Kuros Biosciences AG?
Write Note

Kuros Biosciences AG
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kuros Biosciences AG
Revenue Peer Comparison

Comparables:
ADCT
ACIU
CRSP
MOLN
BSLN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Kuros Biosciences AG
SIX:KURN
Revenue
CHf52.5m
CAGR 3-Years
64%
CAGR 5-Years
108%
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Revenue
$69.6m
CAGR 3-Years
N/A
CAGR 5-Years
129%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Revenue
CHf15.5m
CAGR 3-Years
96%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Revenue
$202.8m
CAGR 3-Years
-39%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Molecular Partners AG
SIX:MOLN
Revenue
CHf10.4m
CAGR 3-Years
19%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Revenue
CHf149m
CAGR 3-Years
10%
CAGR 5-Years
4%
CAGR 10-Years
14%

See Also

What is Kuros Biosciences AG's Revenue?
Revenue
52.5m CHF

Based on the financial report for Jun 30, 2024, Kuros Biosciences AG's Revenue amounts to 52.5m CHF.

What is Kuros Biosciences AG's Revenue growth rate?
Revenue CAGR 5Y
108%

Over the last year, the Revenue growth was 157%. The average annual Revenue growth rates for Kuros Biosciences AG have been 64% over the past three years , 108% over the past five years .

Back to Top